The utility of the prodrug approach to improve peptide absorption
- 31 July 1992
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 21 (1-3) , 63-72
- https://doi.org/10.1016/0168-3659(92)90008-f
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prodrugs of peptides. 15. 4-Imidazolidinone prodrug derivatives of enkephalins to prevent aminopeptidase-catalyzed metabolism in plasma and absorptive mucosaeInternational Journal of Pharmaceutics, 1991
- Chemical stability and plasma-catalyzed dealkylation of peptidyl-α-hydroxyglycine derivatives—Intermediates in peptide α-amidationPeptides, 1991
- Prodrugs for dermal deliveryAdvanced Drug Delivery Reviews, 1989
- Intra- and extravascular turnover of thyrotrophin-releasing hormone in normal manJournal of Endocrinology, 1988
- Peptides and Related Drugs: A Review of Their Absorption, Metabolism, and ExcretionDrug Metabolism Reviews, 1986
- Hydrolysis of N-(α-hydroxybenzyl)benzamide and other N-(α-hydroxyalkyl) amide derivatives: implications for the design of N-acyloxyalkyl-type prodrugsInternational Journal of Pharmaceutics, 1984
- Prodrugs as drug delivery systems. XXX. 4-Imidazolidinones as potential bioreversible derivatives for the α-aminoamide moiety in peptidesInternational Journal of Pharmaceutics, 1984
- Peptides and the blood-brain barrierLife Sciences, 1983
- Blood level and brain distribution of thyrotropin-releasing hormone(TRH) determined by radioimmunoassay after intravenous administration in rats.Journal of Pharmacobio-Dynamics, 1980
- ChymotrypsinCRC Critical Reviews in Biochemistry, 1973